Drug Profile
KLS 0611
Alternative Names: KLS-0611Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Kissei Pharmaceutical
- Class
- Mechanism of Action Mucin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Dry eyes
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Dry-eyes in Japan (Intraocular)